Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biyan No.1 Granule
- Development stage
- Unknown
- Lead developer
- Xiamen University
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Biyan No.1 Granule is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of allergic rhinitis, specifically studied in pediatric populations with moderate to severe persistent symptoms. It is a hospital-made preparation (医院制剂) from Xiamen Traditional Chinese Medicine Hospital in collaboration with Xiamen University. The granule is administered orally and has been evaluated in randomized controlled trials against standard treatments such as loratadine to assess its efficacy in reducing nasal symptoms and improving quality of life. As a TCM product, it likely contains a mixture of botanical extracts intended to provide anti-inflammatory and immunomodulatory effects.
- Other names
- 鼻炎1号颗粒
Beyond the preview
Go deeper on Biyan No.1 Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biyan No.1 Granule.